• Connect with us
    • Information
      • About Us
      • Contact Us
      • Careers
      • Partnerships
      • Advertise With Us
      • Authors
      • Browse Topics
      • Events
      • Disclaimer
      • Privacy Policy
    • Australia
      North America
      World
    Login
    Investing News NetworkYour trusted source for investing success
    • North America
      Australia
      World
    • My INN
    Videos
    Companies
    Press Releases
    Private Placements
    SUBSCRIBE
    • Reports & Guides
      • Market Outlook Reports
      • Investing Guides
    • Button
    Resource
    • Precious Metals
    • Battery Metals
    • Base Metals
    • Energy
    • Critical Metals
    Tech
    Life Science
    Biotech Market
    Biotech News
    Biotech Stocks
    • Biotech Market
    • Biotech News
    • Biotech Stocks

    Naturally Splendid Announces Re-assignment of Director to Advisory Board

    Matthew Spizziri
    Feb. 26, 2016 11:20AM PST
    Biotech Investing

    Naturally Splendid (TSXV:NSP) announced that Mr. Charlie Brink has stepped down from the Board of Directors and has been assigned to the Naturally Splendid Advisory Board where he will focus on advancing a wide spectrum of technologies focused on commercializing cannabinoid opportunities.

    Naturally Splendid (TSXV:NSP) announced that Mr. Charlie Brink has stepped down from the Board of Directors and has been assigned to the Naturally Splendid Advisory Board where he will focus on advancing a wide spectrum of technologies focused on commercializing cannabinoid opportunities.
    As quoted in the press release:

    This assignment to the Advisory Board, allows Mr. Brink to focus on advancing cannabinoid technologies that his company, Full Spectrum Laboratories Limited, has been advancing over the past several years.
    As a member of the Naturally Splendid Advisory Board, Mr. Brink will continue to provide Naturally Splendid with strategic advice in connection with HempOmega™ and the cannabinoid technologies licensed under the restated and amended license agreement (the “Restated and Amended License Agreement”) between Naturally Splendid and Full Spectrum Laboratories Limited (“FSL”), as announced in the September 23, 2015 news release.

    Naturally Splendid CEO, Craig Goodwin, stated:

    FSL has made significant advancements in the area of advanced cannabinoid technologies that requires much more of Mr. Brink’s attention. The benefit to Naturally Splendid is that we have certain rights to the advancements made on the technologies that FSL are funding. In short, FSL has taken the initiative to advance these technologies while assuming the financial responsibilities associated with the research and development and Naturally Splendid will receive certain benefits of the improvements made to these technologies.

    Connect with Naturally Splendid (TSXV:NSP) to receive an Investor Presentation.

    board of directors
    The Conversation (0)

    Go Deeper

    AI Powered
    Vegan Supply to Distribute Plantein Through Foodservice Network & Sell in Retail Store

    Vegan Supply to Distribute Plantein Through Foodservice Network & Sell in Retail Store

    Cannabis Investing

    Naturally Splendid Appoints Douglas Mason as Permanent CEO

    Latest News

    Outlook Reports

    Resource
    • Precious Metals
      • Gold
      • Silver
    • Battery Metals
      • Lithium
      • Cobalt
      • Graphite
    • Energy
      • Uranium
      • Oil and Gas
    • Base Metals
      • Copper
      • Nickel
      • Zinc
    • Critical Metals
      • Rare Earths
    • Industrial Metals
    • Agriculture
    Tech
      • Artificial Intelligence
      • Cybersecurity
      • Gaming
      • Cleantech
      • Emerging Tech
    Life Science
      • Biotech
      • Cannabis
      • Psychedelics
      • Pharmaceuticals

    Featured Biotech Investing Stocks

    More featured stocks

    Browse Companies

    Resource
    • Precious Metals
    • Battery Metals
    • Energy
    • Base Metals
    • Critical Metals
    Tech
    Life Science
    MARKETS
    COMMODITIES
    CURRENCIES
    ×